All Posts: News Release
-
Experimental Therapy Shows Promise in Pancreatic Cancer Clinical Trial
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda). Immunotherapy drugs alone have not shown to be responsive to pancreatic cancer.
Category: News Release
-
Georgetown’s Cancer Center Awarded Top Designation by Federal Government
The National Cancer Institute (NCI), a part of the National Institutes of Health, has awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown University‘s Lombardi Comprehensive Cancer Center in recognition of its high-impact research, community outreach and cancer care. Georgetown Lombardi is the only such center in the Washington area.
Category: News Release
-
New Study: Analysis Supports New Recommendation to Begin Mammogram Screening at 40
Georgetown Lombardi’s Jeanne Mandelblatt, MD, MPH, and Amy Trentham-Dietz, PhD, of University of Wisconsin Carbone Cancer Center, were lead authors of a study informing the updated final recommendation of the United States Preventive Services Task Force regarding breast cancer screening, released April 30
Category: News Release
-
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.
Category: News Release
-
Georgetown Lombardi Gala To Honor Washington Philanthropists, Cancer Advocates
Two cancer advocates and a pair of dedicated philanthropists will be honored at the 36th Annual Lombardi Gala, an annual event dedicated to raising funds for Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Computer Models Fill Critical Knowledge Gaps To Help Reduce Cancer Disparities
Reducing health disparities in incidence and mortality for major types of cancers can be aided by sophisticated computer modeling efforts, according to a new, wide-ranging perspective by researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues. A collection of new studies in the November 8, 2023, special issue of JNCI devoted to cancer disparities modeling outlines a path forward.
Category: News Release
-
Tobacco Regulations Center Receives $20 Million for Tobacco Use Research
The Center for the Assessment of Tobacco Regulations (CAsToR) — a collaboration with Georgetown University, the University of Michigan, and the British Columbia (BC) Cancer Research Institute — recently received $20 million in funding to continue its research on the impact of tobacco regulations on tobacco use patterns and their downstream health effects.
Category: News Release
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level
Using complex molecular tools, researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the cellular level on surrounding healthy tissue.
Category: News Release
-
Novel Research Shows Older Breast Cancer Survivors Experience Accelerated Aging, Worse Functional Outcomes
In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other leading cancer centers from across the nation examined whether cancer and its treatments accelerate aging. Using novel epigenetic measures to assess biological aging, investigators found that older breast cancer survivors — particularly those exposed to chemotherapy — showed greater epigenetic aging than their same-aged peers without cancer, which may relate to worse outcomes.
Category: News Release